Product Details

SereVent Diskus

Salmeterol Xinafoate
50 mcg
Powder for Inhalation
60-Dose Pack

DIN/PIN/NPN

02231129

Manufacturer

GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care

Formulary Listing Date

1998-12-31  

Unit Price

75.2000

Amount MOH Pays

75.2000

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

R03AC12

Interchangeable Products

NO  

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
132 Indefinite

For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.

Note: This drug is not for relief of acute symptoms.

391 Indefinite

For patients with moderate to severe COPD with persistent respiratory symptoms despite an adequate trial of, or an intolerance to, a regularly scheduled short-acting bronchodilator AND a long-acting anticholinergic.

 

EAP Criteria

NO

Product Monograph

View Monograph